RIL
IRON icon

Rothschild Investment LLC’s Disc Medicine IRON Stock Holding History

Rothschild Investment LLC’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Sell
32
-9
-22% -$618 ﹤0.01% 2693
2026
Q1 		$2.62K Buy
41
+1
+3% +$69 ﹤0.01% 2419
2025
Q4 		$3.18K Hold
40
– – ﹤0.01% 2133
2025
Q3 		$2.64K Sell
40
-5
-11% -$297 ﹤0.01% 2058
2025
Q2 		$2.38K Hold
45
– – ﹤0.01% 1949
2025
Q1 		$2.23K Buy
45
+15
+50% +$834 ﹤0.01% 1825
2024
Q4 		$1.9K Buy
30
+10
+50% +$578 ﹤0.01% 1833
2024
Q3 		$983 Buy
20
+15
+300% +$704 ﹤0.01% 2180
2024
Q2 		$225 Buy
+5
New +$170 ﹤0.01% 2450

Other funds holding IRON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Rothschild Investment LLC's IRON Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Disc Medicine (IRON) stake by 22% in Q2 2026, selling an estimated $618 and leaving 32 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Rothschild Investment LLC first reported a position in IRON in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.18K in Q4 2025. 58 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Rothschild Investment LLC held 32 shares of Disc Medicine worth $2.34K as of Q2 2026.
  • Rothschild Investment LLC sold 9 Disc Medicine shares in Q2 2026, an estimated $618.
  • Disc Medicine made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2693 holding.
  • Rothschild Investment LLC first reported a position in Disc Medicine in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Disc Medicine position peaked at $3.18K in Q4 2025.
  • 58 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.